News Releases Webcast Millendo Therapeutics, Inc. at Jefferies 2019 Healthcare Conference 06/06/2019 at 11:00 AM EDT Webcast Millendo Therapeutics, Inc. at 2019 RBC Capital Markets Global Healthcare Conference 05/22/2019 at 10:00 AM EDT Keyword Search Year None20192018201720162015201420132012 Date Title 06/18/19 Millendo Therapeutics Announces Departure of Chief Medical Officer 05/23/19 Millendo Therapeutics to Present at Jefferies 2019 Healthcare Conference 05/15/19 Millendo Therapeutics Reports First Quarter 2019 Operating and Financial Results 05/08/19 Millendo Therapeutics Announces 21st European Congress of Endocrinology 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia 05/02/19 Millendo Therapeutics to Participate in May Investor Conferences 04/24/19 Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 04/02/19 Millendo Therapeutics, Inc. to Present at the 18th Annual Needham Healthcare Conference 03/29/19 Millendo Reports Full Year 2018 Operating and Financial Results 03/19/19 Millendo Therapeutics Initiates Pivotal Phase 2b/3 Clinical Study of Livoletide for the Treatment of Prader-Willi Syndrome 03/14/19 Millendo Therapeutics Announces ENDO 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 14
